Schytte, T., Knap, M. M., Kristiansen, C., Appelt, A. L., Khalil, A., Peucelle, C., Lutz, C. M., Møller, D. S., Sande, E. P., Sundby, F., Persson, G., Schmidt, H., Land, L. H., Rogg, L., Pøhl, M., Lund, M. D., Nielsen, M., Levin, N., Hansen, O., Thing, R. S., Borissova, S., Halvorsen, T., Nielsen, T. B., Hansen, T. S., Haakensen, V. D., Ottosson, W., Brink, C., Hoffmann, L. (2025). Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non–Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco-24-01386